TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01718795

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bag-valve mask or laryngeal tube ventilation
Description: Interventions are either Bag-valve mask (BVM) or Laryngeal tube (LT) ventilation during CPR

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bag-valve mask or laryngeal tube ventilation
Description: Interventions are either Bag-valve mask (BVM) or Laryngeal tube (LT) ventilation during CPR
Study: NCT00056589

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: catridecacog
Description: Single doses of rFXIII administered intravenously (IV) to two subjects in each of the five dose levels (2, 6, 20, 50 and 75 U/kg).
Study: NCT00990457

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Loss Diets Plus Exercise
Description: The weight loss diet will be either a low-carbohydrate diet or a low-fat, low-calorie diet. All participants will also be enrolled in a supervised exercise program.~The supervised exercise training sessions will take place three times a week for 6 months. Each session will last 1 to 1 ½ hours and will include aerobic exercise and weight training.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Loss Diets Plus Exercise
Description: The weight loss diet will be either a low-carbohydrate diet or a low-fat, low-calorie diet. All participants will also be enrolled in a supervised exercise program.~The supervised exercise training sessions will take place three times a week for 6 months. Each session will last 1 to 1 ½ hours and will include aerobic exercise and weight training.
Study: NCT01881490

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRE
Description: Developing the Pediatric Crohn's Disease Intestinal Damage Score (pMEDIC score) and the Pediatric MRE-Based Activity Index (PICMI)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRE
Description: Developing the Pediatric Crohn's Disease Intestinal Damage Score (pMEDIC score) and the Pediatric MRE-Based Activity Index (PICMI)
Study: NCT03403335

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Practices for Health Care Professionals in Training
Description: Eight weekly sessions including didactic lecture, discussion, homework, gentle yoga, and meditation and mindfulness exercises
Study: NCT00474981

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMNCI
Description: Implementation of IMNCI in the intervention sites
Study: NCT01187680

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spraygel

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Good surgical technique, no adhesion barrier
Study: NCT02206581

Intervention type: DEVICE
Intervention: Hydration Monitor
Study: NCT04476589

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional MRI
Description: measurement of functional brain networks
Study: NCT02965287

Intervention type: OTHER
Intervention: Serum metabolomics profiling
Description: The serum samples will be used to get a metabolomic profile

Intervention type: OTHER
Intervention: Serum metabolomics profiling
Description: The serum samples will be used to get a metabolomic profile
Study: NCT03488758

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CMF
Description: Taking a infant formula based on cow milk protein fractions, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GMF
Description: Taking a infant formula based on whole goat milk, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth
Study: NCT01766661

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hand-sewn coloanal anastomosis
Description: After low anterior rectal resection due to low rectal neoplasm patients undergo intestinal reconstructions as hand-sewn coloanal anastomosis with protective loop ileostomy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Two staged Turnbull-Cutait procedure
Description: After low anterior rectal resection due to low rectal neoplasm patients undergo intestinal reconstructions as two staged Turnbull-Cutait procedure anastomosis without protective ileostomy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultralow anterior rectal resection with total mesorectal excision
Description: Standard ultralow anterior rectal resection with total mesorectal excision

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultralow anterior rectal resection with total mesorectal excision
Description: Standard ultralow anterior rectal resection with total mesorectal excision
Study: NCT01564446

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participants will receive a internet based secure message confirming adherence to post-discharge medication regimen
Description: Participants will receive a internet based secure message via My HealtheVet (MHV), The VA's online medical record and secure messaging portal. The message will specify post-discharge prescribed medications and inquire about adherence to these medications.
Study: NCT01931072

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: Interval training 3 times a week for 8 weeks

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Moderate training
Description: Moderate training 3 times a week for 8 weeks
Study: NCT00335192

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks
Description: 3TC (300 mg/24 h, 1 tablet/24 h) + Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h)
Study: NCT03489291

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: AAV5-hFIXco-Padua (AMT-061)
Description: Single intravenous infusion of AAV5-hFIXco-Padua (AMT-061)
Study: NCT00335192

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks
Description: ABV (300 mg/12 h, 1 tablet/12 h)+ Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks
Description: 3TC (300 mg/24 h, 1 tablet/24 h)+ ABV (300 mg/12 h, 1 tablet/12 h)+ Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h).
Study: NCT02296801

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole

Intervention type: DRUG
Group type: OTHER
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib

Intervention type: DRUG
Group type: OTHER
Intervention: palbociclib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Study: NCT04294849

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: A. Phosphorous 31 MR Spectroscopy to evaluate skeletal muscle metabolism via measurement of depletion and recovery of phosphocreatine (PCr) B. Non-invasive arterial spin labeling MRI to evaluate lymphatic flow velocities and venous flow

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bicycle Ergometry
Description: To measure peak VO2 as a representation of global aerobic fitness

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lab Panel
Description: A. Inflammatory lab panel (IL-6, IL-8, TNF alpha, P-selectin, high sensitivity CRP, IL-6 receptor, TNF R1/R2) drawn at diagnosis B. Thrombin Generation Assay to measure hypercoagulability and Thromboelastography prior to initiating anticoagulation

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: A. Dalhousie Dyspnea Scale B. Godin Leisure Time Exercise Questionnaire C. Pediatric Venous Quality of Life Questionnaire
Study: NCT01619449

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Renal replacement therapy
Description: Liver transplant recipients receiving continuous renal replacement therapy for duration of liver transplant surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Description: Liver transplant recipients receiving continuous renal replacement therapy for duration of liver transplant surgery.
Study: NCT00999011

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: once daily mobility activity
Description: in bed and out-of-bed activity including range of motion, chair sitting, sitting at edge of bed without weightbearing, standing, walking.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: twice daily mobility activity
Description: as with once daily. Goal is to progress intensity and duration of activity over time as patient condition improves for both arms
Study: NCT03128060

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based palliative care
Description: The HBPC model consists of home visits by an interdisciplinary primary palliative care team (a physician, nurse, social worker, and chaplain). This team provides pain and symptom management, psychosocial support, advance care planning, spiritual counseling, grief counseling, and other services to meet patient and caregiver needs. Within the first week of a patient's enrollment, team members separately visit the patient at home to assess his/her needs as well as the needs of his/her caregiver. Following the patient's initial assessment, subsequent home visits are based on the patient's and caregiver's needs. At a minimum, a core team member visits the patient at home once per week. Additionally, a 24/7 helpline provides access to nurse counseling and after-hours home visits as needed. As a patient's health declines and he/she becomes eligible for hospice care, HBPC clinicians will refer the patient to hospice.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced usual care
Description: Usual primary care consists of: 1) appointment-based access to primary care providers (PCPs) as requested by the patient; 2) case management services; and 3) provider support through palliative care consultation. These PCPs provide family/internal medicine services as well as access to specialist care. They also offer disease case management and pain and symptom management.~These usual care services are enhanced through training in palliative care provided to PCPs. The training addresses core elements of palliative care, specifically these 6 topics: a palliative care overview; strategies for improving patient-provider communications; instruction in ACP; instruction in managing patients' pain and symptoms; care coordination; and preventing medical crises.
Study: NCT01560988

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Borage and Echium Seed Oils
Description: 4.0 g/day borage seed oil and 7.0 g/day echium seed oil. Pills will be taken three times per day for six weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Borage and Echium Seed Oils
Description: 4.0 g/day borage seed oil and 7.0 g/day echium seed oil. Pills will be taken three times per day for six weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Corn oil pills
Description: Corn oils pills will be taken three times per day for six weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Corn oil pills
Description: Corn oils pills will be taken three times per day for six weeks.
Study: NCT03880409

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% lidocaine with 1:000,000 epinephrine
Description: 2% lidocaine with 1:000,000 epinephrine is dental local anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% lidocaine with 1:000,000 epinephrine
Description: 2% lidocaine with 1:000,000 epinephrine is dental local anesthesia
Study: NCT01161030

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Almonds

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds
Study: NCT02966886

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric Reaming
Description: Pre-operative CT imaging and surgical planning software based on pre-operative CT scans will be used in each case to determine the degree of eccentric (high side) anterior reaming to within \< 10 degrees of neutral glenoid version.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Augmented Glenoid Component Implantation
Description: Patients will undergo standard glenoid preparation and implantation of a posteriorly augmented glenoid component. The degree of posterior augment will be based on pre-operative CT scan assessment and templating software with the goal of correcting glenoid retroversion to within 10 degrees of neutral version.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Augmented Glenoid Component Implantation
Description: Patients will undergo standard glenoid preparation and implantation of a posteriorly augmented glenoid component. The degree of posterior augment will be based on pre-operative CT scan assessment and templating software with the goal of correcting glenoid retroversion to within 10 degrees of neutral version.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior Glenoid Bone Grafting
Description: Patient will undergo a total shoulder arthroplasty as per standard technique. Glenoid version will be restored to within 10 degrees of neutral with a posterior glenoid bone graft. The bone graft will be harvested from the humeral head and fixed to the posterior glenoid with mini-fragment screws.
Study: NCT03593460

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide
Study: NCT01697098

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone 24 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone 12
Study: NCT03658538

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active HEPA Air Cleaner
Description: The active treatment arm will receive two active air cleaners with HEPA and carbon filters to support a home smoking ban and SHS reduction.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motivational interviewing
Description: The active treatment arm will receive 4 sessions of phone based motivational interviewing to support a home smoking ban and SHS reduction (in addition to the smoking cessation counseling received by all study participants).~The Control arm will receive only continued counseling for smoking cessation.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Air Cleaner
Description: The Control arm will receive sham air cleaners
Study: NCT01729585

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Massage Therapy
Description: The Massage Therapy protocol consists of a series of 5 massages administered over 10 (+2) weeks. Length of time for each visit will be approximately 1.5 - 2 hours Typically, a series of treatments over time allows the body time to integrate tissue related changes and potentially maintain a more healthy musculoskeletal state. Based on expert opinion in the field of MT, following a series of massage treatments administered over time, one can anticipate tissue changes. By adding time between treatments, data will describe the ability of subjects to maintain changes over progressively longer periods of time. Treatment protocol will be based on the application of myofascial trigger point therapy (Timberlake, 1999) to musculoskeletal areas of the body often affected by disease progression in CF.
Study: NCT03980951

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dural Puncture Epidural Technique
Description: three labor analgesia techniques

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined Spinal Epidural without intrathecal opioids
Description: three labor analgesia techniques

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: epidural
Description: three labor analgesia techniques
Study: NCT03880409

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4% articaine with 1:000,000 epinephrine
Description: 4% articaine with 1:000,000 epinephrine is dental local anesthesia
Study: NCT00709800

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 0.1 mg/mL, 2 injections, 0 and 21 days

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 0.5 mg/mL, 2 injections, 0 and 21 days

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 1 mg/mL, 2 injections, 0 and 21 days

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPM1
Description: IM, 1 mg/mL, 2 injections, 0 and 21 days

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: PBS
Description: IM, 1 mL, 2 injections, 0 and 21 days
Study: NCT03563872

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Enhancements to team-based care include clinical decision support and improved protocols for telehealth prescribing.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Usual, team-based care
Study: NCT02657239

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MOVE UP
Description: Weight management behavioral program
Study: NCT01944215

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Meal
Description: effect of meal

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: effect of exercise

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sestamibi
Description: reduce radiation dose
Study: NCT00700739

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DISCOVER™ Artificial Cervical Disc
Description: DISCOVER™ Artificial Cervical Disc
Study: NCT01944215

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sestamibi
Description: reduce radiation dose

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sestamibi
Description: reduce radiation dose
Study: NCT00700739

Intervention type: DEVICE
Group type: OTHER
Intervention: ACDF
Description: Cervical CFRP I/F CAGE® and SLIM LOC(R) Anterior Cervical Plate System with allograft
Study: NCT04863560

Intervention type: OTHER
Intervention: Auditory Cueing
Description: Metronome beat to step in time with

Intervention type: OTHER
Intervention: Auditory Cueing
Description: Metronome beat to step in time with
Study: NCT01944215

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sestamibi
Description: reduce radiation dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine Tablet
Description: effect of caffeine

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: External Heating
Description: Heating Pad and warm blanket robe
Study: NCT02128568

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Youth Readiness Intervention
Description: The YRI brings together six empirically-supported practice elements shown to be efficacious across different mental health interventions, as well as methods intended to socialize youth and improve self-efficacy. Practice elements address the broad scope of problems evidenced in Sierra Leonean war-affected youth and enhance the YRI's pacing, which progresses through three phases traditionally used in trauma treatments (stabilization, integration, connection). The weekly intervention takes place over 12 sessions lasting approximately one hour and a half. Groups are divided by gender and age. Each group is paired with two interventionists of the same gender.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention
Description: The YRI brings together six empirically-supported practice elements shown to be efficacious across different mental health interventions, as well as methods intended to socialize youth and improve self-efficacy. Practice elements address the broad scope of problems evidenced in Sierra Leonean war-affected youth and enhance the YRI's pacing, which progresses through three phases traditionally used in trauma treatments (stabilization, integration, connection). The weekly intervention takes place over 12 sessions lasting approximately one hour and a half. Groups are divided by gender and age. Each group is paired with two interventionists of the same gender.
Study: NCT04125745

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CXA-10
Description: Each subject will receive oral CXA-10 at the dose of 300 mg once daily for 12 weeks
Study: NCT00887042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine, Busulfan, Thymoglobulin
Description: fludarabine (40 mg/m2 once daily i.v. on days -8, -7, -6, -5, -4 \& -3) busulfan (0.8 mg/kg every 6 hours i.v. on days -6, -5, -4, \& -3) thymoglobulin (2.5 mg/kg once daily i.v. on days -8, -7, \& -6)
Study: NCT04135781

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab paclitaxel
Description: nab paclitaxel （120mg/m2；iv；d1，8）

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegafur
Description: S-1 （\<1.25 m2, 40 mg; 1.25 to ≤1.5 m2, 50 mg; and ≥ 1.5 m2, 60 mg；po；d1-14 bid）

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: Oxaliplatin（130mg/m2 , iv, d1）
Study: NCT04863560

Intervention type: OTHER
Intervention: Auditory Cueing
Description: Metronome beat to step in time with

Intervention type: OTHER
Intervention: Visual Cueing
Description: Lines on the floor to step over

Intervention type: OTHER
Intervention: Visual Cueing
Description: Lines on the floor to step over

Intervention type: OTHER
Intervention: Visual Cueing
Description: Lines on the floor to step over